| Naslov: | Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma |
|---|
| Avtorji: | ID Oblak, Irena (Avtor)
ID Skoblar Vidmar, Marija (Avtor)
ID Anderluh, Franc (Avtor)
ID Velenik, Vaneja (Avtor)
ID Jeromen, Ana (Avtor)
ID But-Hadžić, Jasna (Avtor) |
|---|
| Datoteke: |  PDF - Predstavitvena datoteka, prenos (519,56 KB)
MD5: 81C786D883587160E5E0E01C94A2EB37
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  OI - Onkološki inštitut Ljubljana
|
|---|
| Povzetek: | Background. In patients with non-metastatic gastric cancer surgery still remains the treatment of choice. Postoperative radiochemotherapy with 5-fluorouracil and leucovorin significantly improves the treatment outcome. The oral fluoropyrimidines, such as capecitabine, mimic continuous 5-fluorouracil infusion, are at least as effective as 5-fluorouracil, and such treatment is more comfortable for the patients. Patients and methods. In the period from October 2006 to December 2009, 101 patients with gastric cancer in stages Ib-IIIc were treated with postoperative chemoradiation with capecitabine. Distal subtotal resection of the stomach was performed in 46.3%, total resection in 50.5% and multivisceral resection in 3.2% of patients. The main endpoints of this study were loco-regional control (LRC), disease-free survival (DFS), disease-specific survival (DSS) and overall survival (OS). The rates of acute side-effects were also estimated. Results. Seventy-seven percent of patients completed the treatment according to the protocol. The median followup time of all patients was 3.9 years (range: 0.4-6.3 years) and in survivors it was 4.7 years (range: 3.2-6.3 years). No death occurred due to the therapy. Acute toxicity, such as nausea and vomiting, stomatitis, diarrhoea, hand-foot syndrome and infections of grade 3 or 4, occurred in 5%, 1%, 2%, 8.9% and 18.8% of patients, respectively. On the close-out date 63.4% patients were still alive and with no signs of the disease. The 4-years follow-up survey showed that LRC, DFS, DSS and OS were 95.5%, 69.2%, 70.7%, and 66.2%, respectively. Higher pN-stage and splenectomy were found to be independent prognostic factors for all four types of survival and perineural invasion and lower treatment intensity for DFS, DSS and OS. |
|---|
| Ključne besede: | gastric cancer, adjuvant therapy, radiochemotherapy |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Datum objave: | 01.06.2014 |
|---|
| Založnik: | Association of Radiology and Oncology |
|---|
| Leto izida: | 2014 |
|---|
| Št. strani: | str. 189-196 |
|---|
| Številčenje: | Vol. 48, no. 2 |
|---|
| Izvor: | Ljubljana |
|---|
| PID: | 20.500.12556/DiRROS-18658  |
|---|
| UDK: | 616.3 |
|---|
| ISSN pri članku: | 1318-2099 |
|---|
| DOI: | 10.2478/raon-2013-0065 |
|---|
| COBISS.SI-ID: | 1617531 |
|---|
| Avtorske pravice: | by Authors |
|---|
| Datum objave v DiRROS: | 11.04.2024 |
|---|
| Število ogledov: | 84 |
|---|
| Število prenosov: | 17 |
|---|
| Metapodatki: |     |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
